Image

Global Oral Drug Delivery Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Jan 2022
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220
  • Healthcare
  • Upcoming Report
  • Jan 2022
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Oral Drug Delivery Market, By Type (Controlled Release, Orodispersible Tablets, Taste Making), Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications), End User (Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.

Oral Drug Delivery Market

Market Analysis and Insights Global Oral Drug Delivery Market

The oral drug delivery market is expected to witness market growth at a rate of 7.60% in the forecast period of 2022 to 2029. Data Bridge Market Research report on oral drug delivery market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the healthcare sector globally is escalating the growth of oral drug delivery market.

Drug delivery systems refer to the type of systems that are employed to deliver therapeutic agents in a controlled manner. Drugs are delivered through various routes such as nasal, intravenous or oral. These drugs can be absorbed through the skin too. Oral drug delivery systems offer tablets and films.

The rise in the geriatric population across the globe acts as one of the major factors driving the growth of oral drug delivery market. The increase in demand for self-administration and home care facilities among people, and surge in demand for investments in pharmaceutical research and development accelerate the market growth. The growth in the biologics market and increase in demand for biosimilar and biologics further influence the market. Additionally, growth in awareness, surge in aging population, improvements in the medical industry and prevalence of chronic diseases positively affects the oral drug delivery market. Furthermore, technological advancements and new product launches extend profitable opportunity to the market players in the forecast period of 2022 to 2029.

On the other hand, risk of needlestick injuries is expected to obstruct the market growth. Pricing pressure is projected to challenge the oral drug delivery market in the forecast period of 2022-2029.

This oral drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on oral drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Oral Drug Delivery Market Scope and Market Size

The oral drug delivery market is segmented on the basis of type, application and end- users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

  • On the basis of type, the oral drug delivery market is segmented into controlled release, orodispersible tablets and taste making.
  • On the basis of application, the oral drug delivery market is segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications.
  • Oral drug delivery market is also segmented on the basis of end- users. The end- users segment is divided into hospitals, ambulatory surgical centers, home care settings, diagnostic centers and others.

Oral Drug Delivery Market Country Level Analysis

The oral drug delivery market is analyzed and market size insights and trends are provided by country, type, application and end- users as referenced above.      

The countries covered in the oral drug delivery market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the oral drug delivery market because of the increase in prevalence of chronic diseases, such as cancer, respiratory allergies, and diabetes within the region. Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in the research and development activities in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The oral drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for oral drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the oral drug delivery market. The data is available for historic period 2010-2020.

Competitive Landscape and Oral Drug Delivery Market Share Analysis

The oral drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to oral drug delivery market.

Some of the major players operating in the oral drug delivery market report are AbbVie Inc., EnteraBio Ltd., Catalent, Inc., Novartis AG, Biocon., Novo Nordisk A/S., F. Hoffmann-La Roche Ltd, Bayer AG, 3M, Evonik Industries, Skyepharma Production SAS, Chimerix., SAMYANG BIOPHARMACEUTICAL CORPORATION, Oramed, Emisphere Technologies, Enteris BioPharma, AdhexPharma., and ARx, LLC., among others.


SKU-

Why Choose Us


Frequently Asked Questions

Oral Drug Delivery Market growth at a rate of 7.60% during the forecast period of 2022 to 2029.
Global Oral Drug Delivery Market segmented By Application such as Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications.
This oral drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.
Some of the major players operating in the oral drug delivery market report are AbbVie Inc., EnteraBio Ltd., Catalent, Inc., Novartis AG, Biocon., Novo Nordisk A/S., F. Hoffmann-La Roche Ltd, Bayer AG, 3M, Evonik Industries, Skyepharma Production SAS, Chimerix., SAMYANG BIOPHARMACEUTICAL CORPORATION, Oramed, Emisphere Technologies, Enteris BioPharma, AdhexPharma., and ARx, LLC., among others.